obesity drug news today glp-1 2025 oct 27 The massive popularity of weight loss drugs is yielding huge donations to Christian causes, thanks to the substantial earnings of the company Eli Lilly. Lilly Endowment, the private, Christian-focused charitable The next phase of the

All patients received 5 mg of oral semaglutide once daily for the first 5 days, then received a dose of 10 mg once daily for the remaining 5 days of the study

Circulation 129(5):587597 van Bommel EJ, Muskiet MH, van Baar MJ, Tonneijck L, Smits MM, Emanuel AL et al (2019) The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

M., Gregg, E

doi: 10.1007/s00432-025-06154-5

Many recent studies also focus on the metabolic aspects of depression, suggesting the involvement of peripheral and central impairments in energy homeostasis, mitochondrial dysfunction, as well as disturbances in the gut-brain axis and gut microbiota dysbiosis as noteworthy factors in the pathogenesis of depression [6,7,8,9]

"It works on key centers of the brain to help reduce emotional eating and cravings," explains Brynna Connor, MD, an Austin-based integrative health expert and ambassador for NorthWestPharmacy.com